Coexpression of CD4 and CD8 alpha on rat T-cells in whole blood: a sensitive marker for monitoring T-cell immunosuppressive drugs

Citation
J. Diaz-romero et al., Coexpression of CD4 and CD8 alpha on rat T-cells in whole blood: a sensitive marker for monitoring T-cell immunosuppressive drugs, J IMMUNOL M, 254(1-2), 2001, pp. 1-12
Citations number
42
Categorie Soggetti
Immunology
Journal title
JOURNAL OF IMMUNOLOGICAL METHODS
ISSN journal
00221759 → ACNP
Volume
254
Issue
1-2
Year of publication
2001
Pages
1 - 12
Database
ISI
SICI code
0022-1759(20010801)254:1-2<1:COCACA>2.0.ZU;2-L
Abstract
The aim of this study was to develop a new quantitative method for measurin g in vitro the effects of T-cell immunosuppressive drugs by flow cytometry. Rat whole blood samples were stimulated with the T-cell mitogen succinylat ed concanavalin A in the presence or absence of different drugs. After 3 da ys, the expression of CD25 and CD8 alpha in mitogen-stimulated CD4(+) cells increased 10- to 20-fold as measured by flow cytometry. Drug efficacy and potency was calculated based on dose-response curves of the drug-mediated d ecrease in CD4(+)/CD8 alpha (+)/CD25(+) cells. The expression of CD8 alpha in mitogen-stimulated CD4(+) cells was blocked completely by calcineurin in hibitors (cyclosporine A and FK-506), and partially by rapamycin and SDZ-RA D. The IC50 (50% inhibitory concentration) values obtained were (mean +/- S .E.): 99.5 +/- 16.6 nM for cyclosporine A, 10.4 +/- 1.3 nM for FK-506, 1.8 +/- 0.7 nM for rapamycin, and 6.4 +/- 1.1 nM for SDZ-RAD. Our results show, for the first time, that CD8 alpha, used as an activation antigen, is a se nsitive marker for monitoring T-cell immunosuppression. (C) 2001 Elsevier S cience B.V. All rights reserved.